Compare SXT & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXT | AMRX |
|---|---|---|
| Founded | 1882 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.0B |
| IPO Year | N/A | N/A |
| Metric | SXT | AMRX |
|---|---|---|
| Price | $98.33 | $13.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $110.00 | $13.25 |
| AVG Volume (30 Days) | 183.5K | ★ 1.5M |
| Earning Date | 02-13-2026 | 02-27-2026 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | ★ 56.32 | N/A |
| EPS | ★ 3.27 | 0.02 |
| Revenue | $1,595,084,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | $4.80 | $9.99 |
| Revenue Next Year | $5.94 | $6.48 |
| P/E Ratio | ★ $29.87 | $852.03 |
| Revenue Growth | 4.25 | ★ 9.50 |
| 52 Week Low | $67.61 | $6.69 |
| 52 Week High | $121.54 | $13.73 |
| Indicator | SXT | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.45 | 65.77 |
| Support Level | $94.74 | $13.08 |
| Resistance Level | $97.63 | $13.34 |
| Average True Range (ATR) | 2.39 | 0.35 |
| MACD | 0.18 | 0.03 |
| Stochastic Oscillator | 77.05 | 87.68 |
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.